Carcinoid and neuroendocrine tumor patients and their families are invited to attend the 2012 NET Patient Half Day Conference on Sunday, January 22 in San Francisco, California. The latest developments in NET cancers, including clinical trials, recent drug approvals, imaging, and current therapies, will be discussed by experts from the University of California San Francisco, Stanford University, Johns Hopkins University, and Vanderbilt University.
Hosting the conference are the NorCal CarciNET Support Group and the UCSF Helen Diller Comprehensive Cancer Center. Josh Mailman, President of NorCal CarciNET, will welcome guests and introduce the speakers. Guests are encouraged to stay and network post conference.
The guest speakers and their topics will be:
- Emily K. Bergland, MD, Professor of Clinical Medicine, UCSF, “Basic Understanding and Treatment of NETs and the Clinical Trials Process”
- George Fisher, MD, Director of the Cancer Clinical Trials Office, Stanford University School of Medicine, “Clinical Trials at Stanford”
- Joseph Herman, MD, radiation oncologist, Johns Hopkins Kimmel Cancer Center, “Palliative Role of Radiation in Patients with Metastatic or Locally Advanced NET”
- Eric Liu, MD, Director of Surgical Services, Vanderbilt Neuroendocrine, Vanderbilt University Medical Center, “Advances in NETs Imaging”
There is a $10.00 registration fee. The conference will be held at the UCSF Mission Bay Campus, Fisher Banquet Auditorium, 1675 Owens Street, San Francisco from 8:30 am to 1:00 pm. CLICK HERE to register.